Ipilimumab vs Lisinopril

## Ipilimumab vs Lisinopril: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Lisinopril**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Lisinopril**: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Lisinopril — 12 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Lisinopril — C21H31N3O5.

**Molecular Weight**: Ipilimumab — N/A; Lisinopril — 405.4900 g/mol.

**Type**: Ipilimumab — Antibody; Lisinopril — Small molecule.